← FDA DRUG APPROVALS

FDA ANDA · ANDA087242

AMINOPHYLLINE

Sponsor: HOSPIRA

APPLICATION
ANDA087242
TYPE
ANDA
ORIGINAL APPROVAL
1983-10-26
LATEST ACTION
1999-07-30
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

AMINOPHYLLINE · ReferencePrescription
AMINOPHYLLINE 25MG/ML · INJECTABLE · INJECTION

Approval history

1999-07-30Manufacturing (CMC) · Supplement 16AP
1997-02-24Manufacturing (CMC) · Supplement 15AP
1996-12-31Labeling · Supplement 13AP
1996-10-03Manufacturing (CMC) · Supplement 14AP
1995-02-01Labeling · Supplement 5AP
1993-12-22Manufacturing (CMC) · Supplement 11AP
1992-08-28Manufacturing (CMC) · Supplement 10AP
1992-03-05Manufacturing (CMC) · Supplement 8AP
1992-03-05Manufacturing (CMC) · Supplement 6AP
1992-03-05Manufacturing (CMC) · Supplement 9AP
1992-03-05Manufacturing (CMC) · Supplement 7AP
1991-04-09Labeling · Supplement 3AP
1990-05-07Labeling · Supplement 4AP
1989-12-27Labeling · Supplement 2AP
1983-10-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →